Columbia Research Enhanced Value ETF (REVS) Chart & Stock Price History $25.39 -0.08 (-0.31%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatings Columbia Research Enhanced Value ETF Stock Price Performance5 Day Performance-0.90%1 Month Performance+0.36%3 Month Performance+6.50%6 Month Performance+10.73%Year-To-Date Performance+17.28%1 Year Performance+26.01% Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… REVS Stock Chart for Saturday, November, 2, 2024 REVS Chart by TradingView Columbia Research Enhanced Value ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$25.47$25.39-0.31%$25.59$25.393,358 shs$45.70 million10/31/2024$25.49$25.47-0.08%$25.52$25.455,637 shs$45.85 million10/30/2024$25.49$25.49+0.00%$25.60$25.435,590 shs$45.88 million10/29/2024$25.62$25.49-0.51%$25.58$25.484,437 shs$45.88 million10/28/2024$25.45$25.62+0.66%$25.66$25.537,718 shs$46.12 million10/25/2024$25.68$25.45-0.90%$25.73$25.453,270 shs$45.81 million Get the Latest News and Ratings for REVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$25.64$25.68+0.16%$25.73$25.623,789 shs$46.22 million10/23/2024$25.72$25.64-0.31%$25.66$25.572,120 shs$46.15 million10/22/2024$25.87$25.72-0.58%$25.75$25.6730,431 shs$46.30 million10/21/2024$25.98$25.87-0.44%$25.97$25.7113,446 shs$46.57 million10/18/2024$25.95$25.98+0.13%$25.98$25.935,385 shs$46.77 million10/17/2024$25.98$25.95-0.12%$26.01$25.9110,543 shs$46.71 million10/16/2024$25.78$25.98+0.78%$25.98$25.874,438 shs$46.76 million10/15/2024$25.81$25.78-0.12%$25.99$25.742,632 shs$46.40 million10/14/2024$25.69$25.81+0.46%$25.81$25.76695 shs$46.46 million10/11/2024$25.37$25.69+1.26%$25.76$25.409,201 shs$46.24 million10/10/2024$25.43$25.37-0.23%$25.46$25.338,965 shs$45.67 million10/09/2024$25.24$25.43+0.74%$25.47$25.115,308 shs$45.77 million10/08/2024$25.35$25.24-0.43%$25.27$25.162,652 shs$45.43 million10/07/2024$25.39$25.35-0.14%$25.45$25.2514,238 shs$45.63 million10/04/2024$25.17$25.26+0.36%$25.34$25.244,963 shs$45.47 million10/03/2024$25.30$25.17-0.51%$25.35$25.1418,159 shs$45.31 million10/02/2024$25.31$25.30-0.04%$25.33$25.293,358 shs$45.54 million10/01/2024$25.38$25.31-0.28%$25.44$25.292,262 shs$45.56 million09/30/2024$25.36$25.38+0.08%$25.40$25.2013,937 shs$45.68 million09/27/2024$25.18$25.36+0.71%$25.50$25.3212,001 shs$45.65 million09/26/2024$25.01$25.18+0.68%$25.18$25.063,014 shs$45.32 million09/25/2024$25.21$25.01-0.79%$25.14$25.004,653 shs$45.02 million09/24/2024$25.18$25.21+0.12%$25.26$25.122,519 shs$45.38 million09/23/2024$25.07$25.18+0.46%$25.21$25.1512,590 shs$45.32 million09/20/2024$25.24$25.07-0.67%$25.15$25.012,636 shs$45.13 million09/19/2024$24.93$25.24+1.24%$25.32$25.159,043 shs$45.43 million09/18/2024$25.00$24.93-0.28%$25.11$24.933,078 shs$44.87 million09/17/2024$24.91$25.00+0.36%$25.13$24.874,155 shs$45 million09/16/2024$24.70$24.91+0.86%$24.91$24.882,140 shs$44.84 million09/13/2024$24.47$24.68+0.86%$24.78$24.653,357 shs$44.42 million09/12/2024$24.40$24.47+0.29%$24.54$24.395,308 shs$44.05 million09/11/2024$24.48$24.40-0.33%$24.40$24.173,582 shs$43.92 million09/10/2024$24.57$24.48-0.37%$24.53$24.354,181 shs$44.06 million09/09/2024$24.45$24.57+0.49%$24.79$24.559,117 shs$44.23 millionTrue paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.09/06/2024$24.62$24.45-0.69%$24.55$24.32236,338 shs$44.01 million09/05/2024$24.87$24.62-0.99%$24.62$24.543,933 shs$44.32 million09/04/2024$24.88$24.87-0.06%$24.89$24.801,854 shs$44.76 million09/03/2024$25.15$24.88-1.07%$25.05$24.885,287 shs$44.78 million09/02/2024$25.15$25.15+0.01%$25.15$24.941,400 shs$45.27 million08/30/2024$24.95$25.15+0.80%$25.15$24.941,422 shs$45.27 million08/29/2024$24.92$24.95+0.12%$25.00$24.894,440 shs$44.91 million08/28/2024$24.88$24.92+0.16%$24.93$24.736,399 shs$44.86 million08/27/2024$24.89$24.88-0.04%$24.94$24.827,832 shs$44.78 million08/26/2024$24.85$24.89+0.18%$25.00$24.853,512 shs$44.80 million08/23/2024$24.49$24.85+1.47%$24.85$24.595,547 shs$44.73 million08/22/2024$24.54$24.49-0.20%$24.60$24.496,271 shs$44.08 million08/21/2024$24.36$24.54+0.76%$24.55$24.459,215 shs$44.17 million08/20/2024$24.48$24.36-0.51%$24.46$24.365,149 shs$43.84 million08/19/2024$24.34$24.48+0.58%$24.51$24.414,692 shs$44.06 million08/16/2024$24.20$24.34+0.58%$24.39$24.193,747 shs$43.81 million08/15/2024$23.93$24.20+1.15%$24.30$24.102,567 shs$43.56 million08/14/2024$23.82$23.93+0.44%$24.00$23.825,681 shs$43.07 million08/13/2024$23.59$23.82+0.97%$23.86$23.654,082 shs$42.88 million08/12/2024$23.73$23.59-0.58%$23.84$23.593,692 shs$42.46 million08/09/2024$23.70$23.73+0.13%$23.79$23.6815,730 shs$42.71 million08/08/2024$23.34$23.70+1.54%$23.77$23.603,954 shs$42.66 million08/07/2024$23.46$23.34-0.53%$23.78$23.347,748 shs$42.01 million08/06/2024$23.23$23.46+1.01%$23.63$23.465,903 shs$42.24 million08/05/2024$23.84$23.23-2.57%$23.34$23.172,377 shs$41.81 million08/02/2024$24.26$23.84-1.73%$23.84$23.752,727 shs$42.91 million08/01/2024$24.56$24.26-1.22%$24.44$24.176,591 shs$43.67 million Related Companies FEBW Stock Chart AZAJ Stock Chart LOWV Stock Chart QARP Stock Chart BSTP Stock Chart AZAO Stock Chart PGRO Stock Chart JULT Stock Chart SPXT Stock Chart MARW Stock Chart Receive REVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:REVS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.